OncoloGIST, BioloGIST, RadioloGIST: the big impact on the field of oncology of a molecularly-targeted therapy designed to treat a rare disease. - Suppr | 超能文献

OncoloGIST, BioloGIST, RadioloGIST: the big impact on the field of oncology of a molecularly-targeted therapy designed to treat a rare disease.

作者信息

Demetri George D

出版信息

Eur J Cancer. 2003 Sep;39(14):1976-7. doi: 10.1016/s0959-8049(03)00555-0.

DOI:10.1016/s0959-8049(03)00555-0

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

OncoloGIST, BioloGIST, RadioloGIST: the big impact on the field of oncology of a molecularly-targeted therapy designed to treat a rare disease.

Eur J Cancer. 2003 Sep;39(14):1976-7. doi: 10.1016/s0959-8049(03)00555-0.

2

[Targeted treatment of cancers with imatinib mesylate (STI571, Gleevec): results of Asco 2002].[甲磺酸伊马替尼（STI571，格列卫）对癌症的靶向治疗：2002年美国临床肿瘤学会年会结果]

Bull Cancer. 2002 Jun;89(6):567-9.

3

KIT and PDGF as targets.

Cancer Treat Res. 2004;120:117-27. doi: 10.1007/1-4020-7856-0_7.

4

[Gain-of-function mutation of c-kit gene and molecular target therapy in GISTs].[胃肠道间质瘤中c-kit基因功能获得性突变与分子靶向治疗]

Nihon Shokakibyo Gakkai Zasshi. 2003 Jan;100(1):13-20.

5

[Molecular and histologic characteristics of secondary imatinib-resistant gastrointestinal stromal tumors].[继发性伊马替尼耐药胃肠道间质瘤的分子与组织学特征]

Zhonghua Bing Li Xue Za Zhi. 2013 Jan;42(1):42-3. doi: 10.3760/cma.j.issn.0529-5807.2013.01.009.

6

Targeting mutant kinases in gastrointestinal stromal tumors: a paradigm for molecular therapy of other sarcomas.

Cancer Treat Res. 2004;120:129-50. doi: 10.1007/1-4020-7856-0_8.

7

[Chemotherapy and target-therapy of gastrointestinal tumors call for development of pathology].[胃肠道肿瘤的化疗与靶向治疗呼唤病理学的发展]

Zhonghua Bing Li Xue Za Zhi. 2007 Jul;36(7):438-9.

8

Testing for KIT (CD117) in gastrointestinal stromal tumors: another HercepTest?胃肠道间质瘤中KIT（CD117）检测：另一种赫赛汀检测法？

Appl Immunohistochem Mol Morphol. 2002 Sep;10(3):197-8. doi: 10.1097/00129039-200209000-00001.

9

Advanced or metastatic gastrointestinal stromal tumors: systemic treatment options.晚期或转移性胃肠道间质瘤：系统治疗选择。

J Surg Oncol. 2011 Dec;104(8):888-95. doi: 10.1002/jso.21930.

10

Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia: is this the real target?甲磺酸伊马替尼治疗c-kit阳性急性髓系白血病：这是真正的靶点吗？

Blood. 2005 Jan 15;105(2):904; author reply 905. doi: 10.1182/blood-2004-08-3088.

引用本文的文献

1

18F-Fluorodeoxyglucose Uptake in PDGFRA-Mutant Gastrointestinal Stromal Tumors.18F-氟脱氧葡萄糖在血小板衍生生长因子受体A（PDGFRA）突变型胃肠道间质瘤中的摄取

JAMA Netw Open. 2025 Jan 2;8(1):e2456058. doi: 10.1001/jamanetworkopen.2024.56058.

2

A clinical and biological overview of gastrointestinal stromal tumors.胃肠道间质瘤的临床与生物学概述

Med Oncol. 2005;22(1):1-10. doi: 10.1385/MO:22:1:001.